Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma



Status:Recruiting
Conditions:Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:2/8/2019
Start Date:March 18, 2016
End Date:December 2020
Contact:Karlyn Pierson, RN
Email:pierson.karlyn@mayo.edu
Phone:507-293-0807

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to determine the response rate and overall survival in patients
that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and
intensity modified radiation therapy (IMRT) as part of their standard of care.

The investigators will consent patients that have been diagnosed with mesothelioma and will
undergo chemotherapy followed by surgery and then IMRT as their standard of care. The
investigators will collect data from past and future medical records as well as data
regarding their health status for their lifetime by reviewing life status, treatment status
and CT scans.

Inclusion Criteria:

- Subject provides informed consent

- Subject is >18 years of age

- Subject is deemed competent for making medical decisions

- Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT

- Subject is a surgical candidate

- A negative pregnancy test is required in women of child-bearing potential, as standard
of care.

Exclusion Criteria:

•Subject is <18 years old.
We found this trial at
1
site
Mayo Clinic Rochester
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Principal Investigator: Dennis A Wigle, MD, PhD
Phone: 507-538-1960
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials